These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 36426205)

  • 21. Evaluation of Antidepressant Effects on Recovery of Electrical Field Stimulation-Induced Contractions that have been Suppressed by Clonidine in Isolated Rat Vas Deferens.
    Obara K; Michino M; Ito M; Ao L; Sawada A; Yamaki F; Matsuo K; Yoshio T; Tanaka Y
    Pharmacology; 2019; 103(3-4):189-201. PubMed ID: 30695779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Switch to mania upon discontinuation of antidepressants in patients with mood disorders: a review of the literature.
    Ali S; Milev R
    Can J Psychiatry; 2003 May; 48(4):258-64. PubMed ID: 12776393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action.
    Marek GJ; McDougle CJ; Price LH; Seiden LS
    Psychopharmacology (Berl); 1992; 109(1-2):2-11. PubMed ID: 1365657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trazodone and mirtazapine: A possible opioid involvement in their use (at low dose) for sleep?
    Schreiber S; Pick CG
    Med Hypotheses; 2020 Mar; 136():109501. PubMed ID: 31759303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of manic switch with antidepressants use in patients with bipolar disorder in a Nigerian neuropsychiatric hospital.
    Fela-Thomas AL; Olotu OS; Esan O
    S Afr J Psychiatr; 2018; 24():1215. PubMed ID: 30473882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder.
    Ferreira Ade A; Neves FS; da Rocha FF; Silva GS; Romano-Silva MA; Miranda DM; De Marco L; Correa H
    J Affect Disord; 2009 Jan; 112(1-3):267-72. PubMed ID: 18534687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats.
    Kaminska K; Rogoz Z
    J Physiol Pharmacol; 2016 Jun; 67(3):471-80. PubMed ID: 27512008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical variables related to antidepressant-induced mania in bipolar disorder.
    Mundo E; Cattaneo E; Russo M; Altamura AC
    J Affect Disord; 2006 Jun; 92(2-3):227-30. PubMed ID: 16546264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.
    Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A
    Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapies for sleep disturbances in dementia.
    McCleery J; Sharpley AL
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of trazodone on insomnia and anxiety in depressed patients: a clinical and sleep EEG study.
    Arriaga F; Cavaglia F; Pires AM; Lam E; Paiva T
    Int J Psychiatry Clin Pract; 1997; 1(4):281-6. PubMed ID: 24946195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melatonin and pro-hypnotic effectiveness of the antidepressant Trazodone: A preliminary evaluation in insomniac mood-disorder patients.
    Giannaccini G; Masala I; Palego L; Betti L; Pacciardi B; Palagini L; Luchini F; Belli S; Lucacchini A; Mauri M
    Clin Biochem; 2016 Oct; 49(15):1152-1158. PubMed ID: 27374436
    [No Abstract]   [Full Text] [Related]  

  • 33. Control charts for monitoring mood stability as a predictor of severe episodes in patients with bipolar disorder.
    Vazquez-Montes MDLA; Stevens R; Perera R; Saunders K; Geddes JR
    Int J Bipolar Disord; 2018 Apr; 6(1):7. PubMed ID: 29616434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trazodone: properties and utility in multiple disorders.
    Mittur A
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):181-96. PubMed ID: 22115401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
    Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
    Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis.
    McGowan NM; Kim DS; de Andres Crespo M; Bisdounis L; Kyle SD; Saunders KEA
    CNS Drugs; 2022 Apr; 36(4):345-363. PubMed ID: 35305257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypomania/mania induced by cessation of antidepressant drugs].
    Kora K; Kaplan P
    Turk Psikiyatri Derg; 2008; 19(3):329-33. PubMed ID: 18791886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
    Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
    Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of the first manic episode in affective disorder: a case register study of hospitalised episodes.
    Kessing LV
    J Affect Disord; 1999 Jun; 53(3):233-9. PubMed ID: 10404709
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.